HDAC8 and hepatocellular carcinoma: Both in rodents and in patients with NAFLD-HCC, the HDAC8/EZH2 complex controls histone H4 acetylation and works as epigenetic silencing machinery on inhibitors of Wingless-related integration site (Wnt)/β-catenin signaling, thus favoring HCC development [123].